Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
8.66
+0.16 (1.88%)
At close: Sep 26, 2025, 4:00 PM EDT
8.74
+0.08 (0.92%)
After-hours: Sep 26, 2025, 6:47 PM EDT
Anavex Life Sciences Market Cap
Anavex Life Sciences has a market cap or net worth of $743.84 million as of September 26, 2025. Its market cap has increased by 71.00% in one year.
Market Cap
743.84M
Enterprise Value
642.68M
1-Year Change
71.00%
Ranking
Category
Stock Price
$8.66
Market Cap Chart
Since October 28, 2015, Anavex Life Sciences's market cap has increased from $284.60M to $743.84M, an increase of 161.36%. That is a compound annual growth rate of 10.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 743.80M | -18.34% |
| Dec 31, 2024 | 910.90M | 19.20% |
| Dec 29, 2023 | 764.20M | 5.86% |
| Dec 30, 2022 | 721.90M | -45.24% |
| Dec 31, 2021 | 1.32B | 264.55% |
| Dec 31, 2020 | 361.60M | 148.69% |
| Dec 31, 2019 | 145.40M | 100.00% |
| Dec 31, 2018 | 72.70M | -48.95% |
| Dec 29, 2017 | 142.40M | -9.24% |
| Dec 30, 2016 | 156.90M | -18.58% |
| Dec 31, 2015 | 192.70M | -32.29% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 641.51B |
| Johnson & Johnson | 428.03B |
| AbbVie | 386.06B |
| UnitedHealth Group | 312.96B |
| Novo Nordisk | 251.02B |
| Novartis AG | 237.03B |
| Abbott Laboratories | 232.02B |
| AstraZeneca | 226.78B |